Hikma’s Pharmaceuticals PLC (Hikma), a worldwide pharmaceutical firm, has announced the appointment of Patrick Genestin as Vice President, Business Development, Generics. Mr. Genestin is a results-oriented managing director with significant financial, business and M&A experience in the pharmaceutical sector, with over 25 years of knowledge. He is stationed in the US headquarters in Berkeley Heights, New Jersey.
Mr. Genestin’s role is to oversee the management of pipelines and establish new growth prospects for Hikma’s generics business, including leading licensing, M&A, proactively finding business growth possibilities, and sustaining and developing the CMO business.”Patrick is an accomplished business development leader with substantial industry experts who will be essential to as we continue to build on our excellent track record,” said Brian Hoffmann, President of Generics.
“Hikma’s Generics business has long been regarded as an industry partner of choice, thanks to its strong production capabilities and superb facilities, good quality record, and demonstrated ability to commercialize. I am very happy to work with the excellent Hikma’s team on this position of strength, lead our pipeline strategy, contribute to the growth and ensure the availability of important generic medicines for patients who rely on them.”